Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial) A Agarwal, A Mukherjee, G Kumar, P Chatterjee, T Bhatnagar, P Malhotra bmj 371, 2020 | 817 | 2020 |
SARS-CoV-2 spike mutations, L452R, T478K, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India S Cherian, V Potdar, S Jadhav, P Yadav, N Gupta, M Das, P Rakshit, ... Microorganisms 9 (7), 1542, 2021 | 496 | 2021 |
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial R Ella, KM Vadrevu, H Jogdand, S Prasad, S Reddy, V Sarangi, ... The Lancet Infectious Diseases 21 (5), 637-646, 2021 | 457 | 2021 |
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial R Ella, S Reddy, W Blackwelder, V Potdar, P Yadav, V Sarangi, VK Aileni, ... The Lancet 398 (10317), 2173-2184, 2021 | 366 | 2021 |
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a … R Ella, S Reddy, H Jogdand, V Sarangi, B Ganneru, S Prasad, D Das, ... The Lancet Infectious Diseases 21 (7), 950-961, 2021 | 361 | 2021 |
Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India PV CherianS, S Jadhav, P Yadav, N Gupta, M Das bioRxiv, 2021 | 323 | 2021 |
Neutralization of variant under investigation B. 1.617. 1 with sera of BBV152 vaccinees PD Yadav, GN Sapkal, P Abraham, R Ella, G Deshpande, DY Patil, ... Clinical Infectious Diseases 74 (2), 366-368, 2022 | 272 | 2022 |
Outbreak investigation of Nipah virus disease in Kerala, India, 2018 G Arunkumar, R Chandni, DT Mourya, SK Singh, R Sadanandan, ... The Journal of infectious diseases 219 (12), 1867-1878, 2019 | 270 | 2019 |
Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020 MV Murhekar, T Bhatnagar, S Selvaraju, K Rade, V Saravanakumar, ... Indian Journal of Medical Research 152 (1-2), 48-60, 2020 | 214 | 2020 |
SARS-CoV-2 antibody seroprevalence in India, August–September, 2020: findings from the second nationwide household serosurvey PY Manoj V Muhrekar, Tarun Bhatnagar The Lancet Global Health 9 (3), e257-e266, 2021 | 193 | 2021 |
Full-genome sequences of the first two SARS-CoV-2 viruses from India PD Yadav, VA Potdar, ML Choudhary, DA Nyayanit, M Agrawal, ... Indian Journal of Medical Research 151 (2-3), 200-209, 2020 | 177 | 2020 |
Detection, isolation and confirmation of Crimean-Congo hemorrhagic fever virus in human, ticks and animals in Ahmadabad, India, 2010–2011 DT Mourya, PD Yadav, AM Shete, YK Gurav, CG Raut, RS Jadi, ... PLoS neglected tropical diseases 6 (5), e1653, 2012 | 147 | 2012 |
Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B. 1.1. 7 variant of SARS-CoV-2 GN Sapkal, PD Yadav, R Ella, GR Deshpande, RR Sahay, N Gupta, ... Journal of Travel Medicine 28 (4), taab051, 2021 | 145 | 2021 |
Emerging/re-emerging viral diseases & new viruses on the Indian horizon DT Mourya, PD Yadav, PT Ullas, SD Bhardwaj, RR Sahay, MS Chadha, ... Indian Journal of Medical Research 149 (4), 447-467, 2019 | 142 | 2019 |
Effect of temperature stress on immature stages and susceptibility of Aedes aegypti mosquitoes to chikungunya virus DT Mourya, P Yadav, AC Mishra American Journal of Tropical Medicine & Hygiene 70 (4), 346-350, 2004 | 129 | 2004 |
Recent ancestry of Kyasanur Forest disease virus R Mehla, SRP Kumar, P Yadav, PV Barde, PN Yergolkar, BR Erickson, ... Emerging infectious diseases 15 (9), 1431, 2009 | 114 | 2009 |
Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin PD Yadav, GN Sapkal, R Ella, RR Sahay, DA Nyayanit, DY Patil, ... Journal of Travel Medicine 28 (7), taab104, 2021 | 102 | 2021 |
Malsoor virus, a novel bat phlebovirus, is closely related to severe fever with thrombocytopenia syndrome virus and heartland virus DT Mourya, PD Yadav, A Basu, A Shete, DY Patil, D Zawar, TD Majumdar, ... Journal of virology 88 (6), 3605-3609, 2014 | 100 | 2014 |
Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques PD Yadav, R Ella, S Kumar, DR Patil, S Mohandas, AM Shete, ... Nature communications 12 (1), 1386, 2021 | 94 | 2021 |
Molecular detection of animal viral pathogens D Liu CRC Press, 2016 | 86 | 2016 |